£67.00

It has never been this cheap. We have no record of a lower price.

£67 today · cheaper than every other day in the last 3 months

Papel da Imuno-histoquímica no Carcinoma da Mama: Classificação molecular do carcinoma da mama através da avaliação da expressão de ER, PR, HER2/neu, Ki-67 e CK5/6

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 61 days · 61 data points (no recent data)

Historical
Generating forecast…
£67.00 £63.65 £64.99 £66.33 £67.67 £69.01 £70.35 25 July 2026 09 August 2026 24 August 2026 08 September 2026 23 September 2026
View at Amazon ↗

Price data last checked 30 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 61 days • 1 price levels

Days at Price
61 days 0 15 31 46 61 £67 Days at Price

Price Analysis

Most common price: £67 (61 days, 100.0%)

Price range: £67 - £67

Price levels: 1 different prices over 61 days

Description

O cancro da mama é o cancro mais comum entre as mulheres, tanto nos países desenvolvidos como nos países em desenvolvimento. Na Índia, é a 2ª causa principal de cancro entre as mulheres precedida pelo cancro do colo do útero.Os tumores da mama com aparências histopatológicas semelhantes podem exibir apresentações clínicas divergentes, agressividade da doença e capacidade de resposta ao tratamento.Os cancros da mama foram categorizados em pelo menos cincogrupos principais que diferem marcadamente em termos de raças/etnias distintas, distribuição do factor de risco, prognóstico, resposta ao tratamento terapêutico, resultados clínicos e tanto a sobrevivência global (SO) como a sobrevivência livre de recidivas: tumores semelhantes a células luminais, subdivididos em luminal A e B , Her-2/neu positivo, semelhante a basal (BCL), e grupo normal semelhante a mamas.Asavaliaçõesderotina do IHC dos cancros mamários podem fornecer não só informação crucial para orientar a gestão clínica, mas também representar uma alternativa válida aos dispendiosos ensaios de genotipagem.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 April 2022
Listed Since
03 May 2022

Barcode

No barcode data available

Similar Products You Might Like

Detection of Early Features of Cancer in Mammography: Image Analysis and Computer Aided Diagnosis
97% match

Detection of Early Features of Cancer in Mammography: Image Analysis and Computer Aided Diagnosis

VDM Verlag

£67.00 07 Sep 2026
Breast Cancer: Carcinogenesis, Cell Growth and Signalling Pathways
97% match

Breast Cancer: Carcinogenesis, Cell Growth and Signalling Pathways

IntechOpen

£158.35 19 Sep 2026
Breast Cancer: From Biology to Medicine
97% match

Breast Cancer: From Biology to Medicine

IntechOpen

£158.35 02 Oct 2026
Mammographie et difficultés diagnostiques des affections mammaires: Place de la mammographie dans le diagnostic des affections mammaires au CHUYO/Burkina Faso
97% match

Mammographie et difficultés diagnostiques des affections mammaires: Place de la mammographie dans le diagnostic des affections mammaires au CHUYO/Burkina Faso

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£60.00 01 Oct 2026
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-1 (The Clinics: Internal Medicine, Volume 37-1)
97% match

Breast Cancer, An Issue of Hematology/Oncology Clinics of North America: Volume 37-1 (The Clinics: Internal Medicine, Volume 37-1)

Elsevier

£76.99 17 Sep 2026
Breast Cancer Biology
97% match

Breast Cancer Biology

IntechOpen

£118.98 24 Sep 2026
Management of Benign and Malignant Breast Disease, An Issue of Obstetrics and Gynecology Clinics: Volume 49-1 (The Clinics: Internal Medicine, Volume 49-1)
97% match

Management of Benign and Malignant Breast Disease, An Issue of Obstetrics and Gynecology Clinics: Volume 49-1 (The Clinics: Internal Medicine, Volume 49-1)

Elsevier

£76.69 18 Sep 2026
Первичная расширенная диагностика рака молочной железы с использованием медицинской визуализации: Исследование 502 случаев в Уагадугу: Issledowanie 502 sluchaew w Uagadugu
97% match

Первичная расширенная диагностика рака молочной железы с использованием медицинской визуализации: Исследование 502 случаев в Уагадугу: Issledowanie 502 sluchaew w Uagadugu

£58.00 02 Oct 2026
Breast Cancer: An Issue of Oncology Clinics
96% match

Breast Cancer: An Issue of Oncology Clinics

Foster Academics

£68.55 23 Sep 2026
Breast Cancer: Current and Alternative Therapeutic Modalities
96% match

Breast Cancer: Current and Alternative Therapeutic Modalities

IntechOpen

£156.92 24 Sep 2026
Breast Cancer Pathophysiology: An Interdisciplinary Approach (Interdisciplinary Cancer Research, 5)
96% match

Breast Cancer Pathophysiology: An Interdisciplinary Approach (Interdisciplinary Cancer Research, 5)

Springer

£154.66 05 Sep 2026
Efecto peri y paraneoplásico en caninos (perras) con neoplasia mamaria: Histopatología, histoquímica, morfometría y ultraestructura del tejido neoplásico, perineoplásico y muscular esquelético
96% match

Efecto peri y paraneoplásico en caninos (perras) con neoplasia mamaria: Histopatología, histoquímica, morfometría y ultraestructura del tejido neoplásico, perineoplásico y muscular esquelético

VDM Verlag

£73.00 07 Sep 2026
Overview of Inflammatory Breast Cancer: Updates: Volume 384 (International Review of Cell and Molecular Biology, Volume 384)
96% match

Overview of Inflammatory Breast Cancer: Updates: Volume 384 (International Review of Cell and Molecular Biology, Volume 384)

Elsevier

£151.84 21 Aug 2026
Screening and Risk Reduction Strategies for Breast Cancer: Imaging Modality and Risk-Reduction Approaches
96% match

Screening and Risk Reduction Strategies for Breast Cancer: Imaging Modality and Risk-Reduction Approaches

Springer

£83.55 03 Oct 2026
Étude corrélationnelle sur l'auto-examen des seins dans la prévention du cancer
96% match

Étude corrélationnelle sur l'auto-examen des seins dans la prévention du cancer

£50.00 22 Sep 2026
Academic Press AI-Driven Precision Medicine for TNBC Book
96% match

Academic Press AI-Driven Precision Medicine for TNBC Book

Elsevier

£124.04 03 Oct 2026
Current Trends in Breast Cancer Pathology, Screening, Diagnosis and Treatments
96% match

Current Trends in Breast Cancer Pathology, Screening, Diagnosis and Treatments

Elsevier

£132.99 02 Oct 2026
Circulating Immune Complexes: Link to Tumourigenesis: Epigenetic Cell Alteration and Molecular Expressions in Breast Tumourigenesis
96% match

Circulating Immune Complexes: Link to Tumourigenesis: Epigenetic Cell Alteration and Molecular Expressions in Breast Tumourigenesis

LAP Lambert Academic Publishing

£69.00 18 Sep 2026
Diagnosis and Treatment of Breast Cancer
96% match

Diagnosis and Treatment of Breast Cancer

Foster Academics

£71.25 30 Sep 2026
Shadows Beneath the Skin: Unmasking the Truths of Breast Carcinoma in Modern India
96% match

Shadows Beneath the Skin: Unmasking the Truths of Breast Carcinoma in Modern India

£190.00 15 Dec 2025
HMGA1 and Cancer Progression: Molecular Genetics of HMGA1-mediated malignant transformation of breast cancer cells
96% match

HMGA1 and Cancer Progression: Molecular Genetics of HMGA1-mediated malignant transformation of breast cancer cells

LAP Lambert Academic Publishing

£52.00 18 Sep 2026
Breast Cancer Research and Treatment: Innovative Concepts: 188 (Cancer Treatment and Research, 188)
96% match

Breast Cancer Research and Treatment: Innovative Concepts: 188 (Cancer Treatment and Research, 188)

Springer

£88.21 24 Sep 2026
Breast Cancer
96% match

Breast Cancer

Foster Academics

£69.24 01 Oct 2026
The 2023-2028 Outlook for Breast Cancer Screenings in the United States
96% match

The 2023-2028 Outlook for Breast Cancer Screenings in the United States

£520.00 22 Aug 2026